Article info
PDFClinical science
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group
- Correspondence to Dr Lihteh Wu, Asociados de Macula Vitreo y Retina de Costa Rica, San Jose 10102, Costa Rica; lw65{at}cornell.edu
Citation
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group
Publication history
- Received September 7, 2017
- Revised December 27, 2017
- Accepted January 25, 2018
- First published February 8, 2018.
Online issue publication
November 22, 2018
Article Versions
- Previous version (8 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.